Compare SLGL & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLGL | HUIZ |
|---|---|---|
| Founded | 1997 | 2006 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.8M | 35.2M |
| IPO Year | 2018 | 2020 |
| Metric | SLGL | HUIZ |
|---|---|---|
| Price | $44.02 | $3.55 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $50.00 | $2.30 |
| AVG Volume (30 Days) | ★ 15.4K | 4.0K |
| Earning Date | 11-20-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $18,970,000.00 | ★ $186,519,166.00 |
| Revenue This Year | $121.82 | $22.67 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ N/A | $14.22 |
| Revenue Growth | ★ 62.04 | 19.12 |
| 52 Week Low | $4.02 | $1.50 |
| 52 Week High | $52.26 | $4.53 |
| Indicator | SLGL | HUIZ |
|---|---|---|
| Relative Strength Index (RSI) | 50.95 | 54.33 |
| Support Level | $38.37 | $3.46 |
| Resistance Level | $43.90 | $3.79 |
| Average True Range (ATR) | 4.01 | 0.18 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 41.27 | 51.98 |
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.